The 2026 Termeer Fellows Program is hosted by the Termeer Institute and supports first-time CEOs of early-stage life sciences companies—including diagnostics, therapeutics, or medical devices—who have raised between $100K and $40M (seed or Series A).

This program provides leadership development, business-building resources, and access to a peer community of biotech leaders, with opportunities such as the Transatlantic Connections Award for strengthening ties between the U.S. and the Netherlands.

The pre-screen for the next cohort is open through October 10, 2025, and those selected will be invited to complete the full application. Apply here, watch the overview video, or email programs@termeerinstitute.org for questions.